Clinical trial
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
- Lead sponsor
- Institut Pasteur
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2019
- Completion date
- October 26, 2022
- Enrollment
- 14 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
fibrosis, hepatopathy